Clinical Trial: A Study to Learn How Different Amounts of the Study Medicine Called PF-07985631 Are Tolerated and Act in the Body in Healthy Adults

U.S., Nov. 20 -- ClinicalTrials.gov registry received information related to the study (NCT07235150) titled 'A Study to Learn How Different Amounts of the Study Medicine Called PF-07985631 Are Tolerated and Act in the Body in Healthy Adults' on Nov. 14.

Brief Summary: The purpose of this study is to learn about the safety and effects of the study medicine (called PF-07985631) for the possible treatment of a kidney disease called IgA nephropathy.

This study is seeking participants who

* are male or female between 18 and 45 years of age (55 for Japanese/Chinese/multiple dose participants)

* are deemed to be healthy Participants in this study will receive PF-07985631 or placebo. A placebo does not have any medicine in it but looks just lik...